Cellecta, Inc. Announces Upcoming Presentations on CRISPR and RNA Expression Profiling Technologies at AACR 2017

Cellecta, Inc. has announced that it will deliver three scientific presentations at the upcoming American Association for Cancer Research (AACR) 2017 Annual Meeting. Cellecta researchers will present unpublished data on technology developments in genetic screens in human cancer cell lines using CRISPR-knockout, CRISPRi-repression, and CRISPRa-activation; as well as new data on applications of the Driver-Map™ targeted RNA expression solution for profiling immunity biomarkers and cellular composition analysis.

Details of the presentations are as follows:

Poster Abstract 403/ Poster 3: CRISPR/Cas9 genome-wide sgRNA libraries for loss-of-function and gain-of-function genetic screens
Session: Genomic Screening for Cancer Dependencies and Drug Response
Date and Time: Sunday, April 2, 2017, 1:00 - 5:00 p.m. Eastern Time
Location: Convention Center, Halls A-C, Poster Section 17

Spotlight Theatre Presentation: Driver-Map™ Assay: Gene expression profiling of protein-coding genes for tumor microenvironment analysis and biomarker discovery
Date and Time: Tuesday, April 4, 2017, 10:00 – 11:00 a.m. Eastern Time
Location: Convention Center, Spotlight Theatre B – Hall A

Poster Abstract 4652/ Poster 13: Profiling of immunity biomarkers in whole blood
Session: Diagnostic Biomarkers
Date and Time: Tuesday, April 4, 2017, 1:00 - 5:00 p.m. Eastern Time
Location: Convention Center, Halls A-C, Poster Section 28